Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-Sequencing analysis of control and KDSR KO cancer cell lines

ABSTRACT: The mRNA profiles of 3 cell lines (HUH7, DLD1, NCIH838) were analyzed by RNA-sequencing under control and KDSR KO conditions to identify gene expression changes induced by disruption of KDSR in cancer cells that are sensitive to its loss.

ORGANISM(S): Homo sapiens

PROVIDER: GSE182179 | GEO | 2022/09/27

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-Sequencing analysis of control and UXS1 KO A549 cells

Project description:The mRNA profiles of A549 cell line were analyzed by RNA-sequencing under control and UXS1 KO conditions to identify gene expression changes induced by disruption of UXS1.

2023-10-27 | GSE240344 | GEO

Differential Gene expression of furin knockout (KO) DLD1, HCA7 and HT29 colorectal cancer cells

Project description:We created furin KO cells in three colorectal cancer cell lines (DLD1, HCA7 and HT29) using CRISPR-Cas9 genome editing. And then we performed RNA-Seq analysis in furin KO colorectal cancer cells to identify potential effect of furin on gene expression patterns in DLD1, HCA7 and HT29 cells.

2020-03-15 | GSE130969 | GEO

Ribosome profiling sequencing (Ribo-seq) in Huh7 control and SMYD5 KO cells upon normal condition or Torin1 treatment

Project description:To understand how RPL40 K22me3 transferred by SMYD5 affected ribosome function on normal culture condition or after mTOR inhibition, we conducted ribosome profiling sequencing (Ribo-seq) in Huh7 control (NC) and SMYD5 KO cells.

2024-09-30 | GSE241588 | GEO

Gene expression changes between control and C1orf112-knockout (KO) human multiple myeloma (MM) cell lines

Project description:To examine the effect of C1orf112 disruption on the gene expression changes in MM cells , we generated C1orf112-KO cells with KMS-11, OPM-2, and ANBL-6 cells. The control and C1orf112-KO MM cells were incubated for 48 h in the typical cell culture medium.

2023-06-01 | GSE223650 | GEO

ZNF692 organizes a hub for ribosome maturation enhancing translation in rapidly proliferating cells

Project description:Human cancer cell lines (DLD1 wt or ZNF692 KO, and for IP-proteomics HCT116 transfected with GFP, GFP-ZNF692 and deltaNolsZNF692). 788570, HCT116 transfected with GFP; 788571, HCT116 transfected with GFP-ZNF692; 788572, HCT116 transfected with deltaNolsZNF692; 937612, control 40S subunit from DLD1 cells; 937613, control 60S subunit from DLD1 cells; 937614, control 80S monosome fraction from DLD1 cells; 937615, KO ZNF692 40S subunit from DLD1 cells; 937616, KO ZNF692 60S subunit from DLD1 cells; 937617, KO ZNF692 80S monosome fraction from DLD1 cells; 943031, control 40S subunit from DLD1 cells; 943032, control 60S subunit from DLD1 cells; 943033, control 80S monosome fraction from DLD1 cells; 943034, KO ZNF692 40S subunit from DLD1 cells; 943035, KO ZNF692 60S subunit from DLD1 cells; 943036, KO ZNF692 80S monosome fraction from DLD1 cells

2022-04-18 | MSV000089271 | MassIVE

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Project description:This first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess KO-2806, a farnesyl transferase inhibitor (FTI), as a monotherapy and in combination, in adult patients with advanced solid tumors.

| 91122 | ecrin-mdr-crc

RNA-seq of CD33 KO and control HSPCs

Project description:Gene expression profile of in vitro differentiated control and CD33 KO CD34+ cells (with 70-85% CD33 KO) were analyzed by RNA-seq to exclude any major impact of CD33 loss on downstream gene expression

2018-04-26 | GSE113670 | GEO

RNA-Sequencing analysis of control and KDSR KO cancer cell lines

Project description:RNA-Sequencing analysis of control and KDSR KO cancer cell lines

| PRJNA755272 | ENA

Proteomics analysis of non-small cell lung cancer cell lines lacking ATGL (ATGL-KO) or MGL (MGL-KO) or expressing both (Control, NTC)

Project description:Adipose Triglyceride Lipase (ATGL) and Monoglyceride Lipase (MGL) are two enzymes that contribute to intracellular neutral lipolysis by breaking down triglycerides stored within lipid droplets. Recently, lipid droplet accumulation has been described as a novel hallmark of cancer. While lipid metabolism has been investigated in cancer in recent decades, the role of lipid hydrolysis and its enzymes have not been in the focus of cancer research. We and others have found that lipid hydrolysis enzymes might play an important role in the development and progression of lung cancer. To this end, we chose four different non-small cell lung cancer cell lines and employed CRISPR-Cas9 gene editing to knock out either ATGL (ATGL-KO) or MGL (MGL-KO), and a non-targeting control (NTC) was employed to generate a control cell line within each parental cell type. We then performed label free quantitative proteomics to identify differences between the generated cell lines and confirmed ATGL-KO in ATGL-KO cell lines as well as MGL-KO in MGL-KO cell lines. Furthermore, dihydroorotate dehydrogenase (DHODH), an enzyme that is important in some cancer, was upregulated in some, but not all, of the NSCLC cancer cell lines lacking either one of the two lipases.

2023-11-27 | PXD046912 | Pride

MicroRNA profiling in human colon cancer cell lines

Project description:MicroRNA profiling in colon cancer cell lines. Two cell lines have been found with impairment on the export of precursor miRNAs into the cytoplasm (XPO5), HCT15 and DLD1. To test the microRNAs involved several comparisons have been performed: DLD1 and HCT15 cell lines have been compared with XPO5 wild-type cell lines (HCT116 and RKO). Furthermore the transfected XPO5 wild-type defective cells (DLD1.XPO5 wt and HCT15.XPO5 wt) have been compared respect to the non-transfected cells (HCT15 and DLD1). Finally the cell lines HCT15 and DLD1 transfected with a negative control (HCT15.XPO5 358-366 and DLD1.XPO5 358-366) have been compared with respect to non-transfected cell lines (HCT15 and DLD1).

2010-12-31 | E-MTAB-160 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data